The Interatrial shunt is intended for insignificantly obtrusive delivery to the heart using trans catheter systems. The dime-sized gadget is embedded into the septal wall between the atrial chambers, and enables blood to travel from the left chamber to the right chamber.
The device is deployed after trans-septal puncture of the mid–fossa ovalis, positioning the delivery catheter into the left atrium and deploying the left atrial disc, verifying the right atrial location of the delivery catheter, and then deploying the right atrial disc such that the device is secured across the atrial septum and sits flush on the left atrial side.
Prevalent HFpEF represents generally 50% of the current heart failure (HF) trouble, and the rate of HFpEF is expanding with regards to a aging population together with accompanying hypertension, diabetes, and obesity is the prime propelling factor for the growth of Interatrial Shunt market.
All-cause mortality in HFpEF is significantly more noteworthy than that in age matched people. The overall commitment of death due to noncardiovascular occasions in HFpEF is to some degree higher than in HFrEF. Insertion of an interatrial shunt device (IASD) to lessen left atrial weight in HFpEF has been demonstrated to be related with short-term hemodynamic and symptomatic advantage.
The reimbursement and cost of surgery may restraint the growth of interatrial shunt market.
Heart failure (HF) patients with either reduced ejection fraction or preserved ejection fraction experience a high death rate. The latest pharmacologic development for treating patients with HF with decreased discharge part has been with sacubitril/valsartan. Alongside pharmaceutical research, there has been interest for device based treatments as another treatment approach.
One novel interventional device treatment that has indicated in early tests and preliminaries is the interatrial shunt device created by Corvia Medical Inc. and V-Wave gadget by V-Wave Ltd. Embedded between the atria in the atrial septum, both devices make a left-to-right unidirectional shunt.
Based on Indication type the interatrial shunt market is segmented as Heart failure with preserved ejection fraction and Heart failure with reduced ejection fraction. Based on end user interatrial shunt market is segmented as hospitals, Clinic and cardiac centers.
Geologically, North America is leading contributor to the interatrial shunt market and is required to hold its situation during the forecasted time frame because of the presence of huge number of geriatric population, and huge base of patients with heart disorders.
Europe is relied upon to be the second-biggest interatrial shunt market in the estimate time frame. Development of the interatrial shunt market in the region can be credited to increasing case of heart failure and associated heart related disorders and increasing number of heart procedures in Europe.
However, Asia-Pacific market is relied upon to develop at a rapid rate during the conjecture time frame. This is predominantly due to increased number of cardiac centers, hospitals and development in healthcare infrastructure, technological progressions, and developing awareness among the populace about the treatment choices accessible in the market.
The key market players operating in the interatrial shunt market are Corvia Medical Inc.,Tewksbury, MA, USA)
The research report presents a comprehensive assessment of the interatrial shunt market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to interatrial shunt market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global interatrial shunt market is segmented based on the indications, end user and region
By Indication type the interatrial shunt market is segmented as:
By end user interatrial shunt market is segmented as:
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Shunt Voltage References Market
Shunt Reactor Market Growth – Trends & Forecast 2020 to 2030
Fixed Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Variable Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Three Phase Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Controllable Shunt Reactor for UHV Market Size and Share Forecast Outlook 2025 to 2035
Oil Immersed Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Single Phase Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Utility Based Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Hydrocephalus Shunt Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Air Core Fixed Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Renewable Based Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Air Core Variable Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Single Phase Variable Shunt Reactor Market Size and Share Forecast Outlook 2025 to 2035
Interatrial Shunt Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
